Invesco’s MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A MR Stock Holding History

Invesco’s Portfolio MR Stock Details MR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-139,669	Closed	-$3.06M	–	3795
2015 Q3	$3.06M	Sell	139,669 -13,633	-9%	-$348K	﹤0.01%	2208
2015 Q2	$4.37M	Sell	153,302 -800,187	-84%	-$23.3M	﹤0.01%	2091
2015 Q1	$26.1M	Sell	953,489 -42,180	-4%	-$1.16M	0.01%	1087
2014 Q4	$26.3M	Sell	995,669 -197,921	-17%	-$5.79M	0.01%	1076
2014 Q3	$36M	Sell	1,193,590 -462,420	-28%	-$14.3M	0.01%	948
2014 Q2	$52.2M	Sell	1,656,010 -841,927	-34%	-$26.7M	0.02%	781
2014 Q1	$80.8M	Sell	2,497,937 -313,669	-11%	-$11M	0.03%	571
2013 Q4	$102M	Buy	2,811,606 +195,204	+7%	+$7.59M	0.04%	501
2013 Q3	$102M	Buy	2,616,402 +110,929	+4%	+$4.47M	0.04%	465
2013 Q2	$93.8M	Buy	+2,505,473	New	+$98.9M	0.04%	461

Other funds holding MR

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

GAM

Genesis Asset Managers Guernsey, Channel Islands, United Kingdom $3.53B AUM 1.54% 1-Year Est. Return

PRCM

Pine River Capital Management Minnetonka, Minnesota $32.9M AUM 4.47% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

TCA

Taconic Capital Advisors New York $229M AUM 110.07% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Invesco's MR Position: Q4 2015 in Review

Invesco sold out of MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A (MR) in Q4 2015, closing a stake of 139,669 shares — an estimated $3.06M sold.

Invesco first reported a position in MR in Q2 2013 and held it in 10 quarters. The position peaked at $102M in Q4 2013. 119 funds tracked by Wall St. Rank hold MR as of Q4 2015.

Invesco reported no remaining MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position as of Q4 2015 after selling out during the quarter.
Invesco sold 139,669 MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A shares in Q4 2015, an estimated $3.06M.
Invesco first reported a position in MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A in Q2 2013 and held it in 10 quarters.
Invesco's MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position peaked at $102M in Q4 2013.
119 funds tracked by Wall St. Rank held MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A as of Q4 2015.

Based on Invesco's 13F filing for Q4 2015, filed 16 Feb 2016.